Early and multiple origins of metastatic lineages within primary tumors
暂无分享,去创建一个
Atila Iamarino | J. Townsend | D. Rimm | R. Lifton | J. Schlessinger | S. Gaffney | Z. Zhao | Bixiao Zhao | Yalai Bai | Z. Zhao | Z. Zhao | Zi-Ming Zhao | Zi-Ming Zhao
[1] Y. Tokuda,et al. Fundamental study on the mechanism of DNA degradation in tissues fixed in formaldehyde. , 1990, Journal of clinical pathology.
[2] M. Coptcoat,et al. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study. , 1991, British journal of urology.
[3] R. Weinberg. Tumor suppressor genes , 1993, Neuron.
[4] V. Torri,et al. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] P. Stanton,et al. Cell kinetics in vivo of human breast cancer , 1996, The British journal of surgery.
[6] R. Kucherlapati,et al. Mutation in the Mismatch Repair Gene Msh6 Causes Cancer Susceptibility , 1997, Cell.
[7] B. Harfe,et al. DNA mismatch repair and genetic instability. , 2000, Annual review of genetics.
[8] D A Rew,et al. Cell production rates in human tissues and tumours and their significance. Part II: clinical data. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] Richard D. Wood,et al. Human DNA Repair Genes , 2001, Science.
[10] N. Masumori,et al. Growth rates of primary and metastatic lesions of renal cell carcinoma , 2001, International journal of urology : official journal of the Japanese Urological Association.
[11] M. Schofield,et al. DNA mismatch repair: molecular mechanisms and biological function. , 2003, Annual review of microbiology.
[12] Joe W Gray,et al. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. , 2003, Cancer cell.
[13] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[14] R. Hynes. Metastatic Potential Generic Predisposition of the Primary Tumor or Rare, Metastatic Variants—Or Both? , 2003, Cell.
[15] Michael P. Cummings,et al. PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .
[16] W. Frankel,et al. MSH6 missense mutations are often associated with no or low cancer susceptibility , 2004, British Journal of Cancer.
[17] Tomas Lindahl,et al. Human DNA repair genes, 2005. , 2005, Mutation research.
[18] R. Demicheli,et al. Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? , 2005, European journal of cancer.
[19] Derrick J. Zwickl. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion , 2006 .
[20] Ziheng Yang,et al. Computational Molecular Evolution , 2006 .
[21] P. Leung,et al. Gonadotropins and ovarian cancer. , 2007, Endocrine reviews.
[22] Ziheng Yang. PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.
[23] Stella K Kang,et al. Distribution of renal tumor growth rates determined by using serial volumetric CT measurements. , 2009, Radiology.
[24] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[25] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[26] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[27] M. Lynch. Rate, molecular spectrum, and consequences of human mutation , 2010, Proceedings of the National Academy of Sciences.
[28] D. Bar-Sagi,et al. Regulating the regulator: post-translational modification of RAS , 2011, Nature Reviews Molecular Cell Biology.
[29] S. Mane,et al. K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension , 2011, Science.
[30] Jeffrey P Townsend,et al. Phylogenetic signal and noise: predicting the power of a data set to resolve phylogeny. , 2012, Systematic biology.
[31] Maxim Teslenko,et al. MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space , 2012, Systematic biology.
[32] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[33] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[34] Kevan M. Shokat,et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.
[35] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[36] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[37] Peter Donnelly,et al. Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.
[38] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[39] Peter Donnelly,et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.
[40] Shanghai Yu,et al. SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression. , 2014, Cancer research.
[41] Esti Yeger-Lotem,et al. Cancer Evolution Is Associated with Pervasive Positive Selection on Globally Expressed Genes , 2014, PLoS genetics.
[42] D. Dietrich,et al. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors , 2014, Nature Genetics.
[43] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[44] G. Tseng,et al. High Fidelity Copy Number Analysis of Formalin-Fixed and Paraffin-Embedded Tissues Using Affymetrix Cytoscan HD Chip , 2014, PloS one.
[45] L. Saal,et al. Molecular and genetic diversity in the metastatic process of melanoma , 2014, The Journal of pathology.
[46] P. Stephens,et al. A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice. , 2014, The oncologist.
[47] J. Stivers,et al. Microscopic mechanism of DNA damage searching by hOGG1 , 2014, Nucleic acids research.
[48] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[49] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[50] R. Jain,et al. Using tumour phylogenetics to identify the roots of metastasis in humans , 2015, Nature Reviews Clinical Oncology.
[51] Woo Suk Hong,et al. Inferring the Origin of Metastases from Cancer Phylogenies. , 2015, Cancer research.
[52] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.